Close

Elena Verdú, MD, PhD

Associate Professor, Department of Medicine

Canada Research Chair in Inflammation, Microbiota and Nutrition

Director of the Axenic Gnotobiotic Unit

Email: verdue@mcmaster.ca

Lab web site: www.verdulab.ca

Research Areas

I am interested in the pathogenesis of chronic inflammatory disorders such as celiac disease and inflammatory bowel disease. I investigate dietary-bacterial interactions and how this impacts the pathogenesis of gastrointestinal disease, with the view to develop novel therapeutic strategies for these disorders.

Focus

The main focus of research is to study host-microbial and dietary interactions and their role in the pathophysiology of chronic gastrointestinal inflammatory diseases. Work in my lab deals with the way commensal bacteria and food components interact with host tissues to enhance or prevent susceptibility to inflammation. We use a variety of molecular, mouse humanized models and clinical translational approaches to determine whether and how gluten-induced immunopathology is modulated by the small intestinal microbiota. Another important research interest investigates the role of the intestinal microbiota in the induction of mucosal barrier dysfunction and immune responses in the host that are of relevance in inflammatory bowel disease development. As director of the Axenic Gnotobiotic Facility at McMaster, we rederive transgenic mouse strains of interest to perform gnotobiotic colonizations using clinical isolates. The long term goal is to identify novel therapeutic targets to treat celiac disease and inflammatory bowel disease.

  1. Bai, JC, Verdú, EF. The CD That Pays Dividends: More Than 15 Years of Deamidated Gliadin Peptide Antibodies. Dig. Dis. Sci. 2017; :. doi: 10.1007/s10620-017-4528-8. PubMed PMID:28315033 .
  2. De Palma, G, Lynch, MD, Lu, J, Dang, VT, Deng, Y, Jury, J et al.. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci Transl Med. 2017;9 (379):. doi: 10.1126/scitranslmed.aaf6397. PubMed PMID:28251905 .
  3. Pinto-Sánchez, MI, Smecuol, EC, Temprano, MP, Sugai, E, González, A, Moreno, ML et al.. Bifidobacterium infantis NLS Super Strain Reduces the Expression of α-Defensin-5, a Marker of Innate Immunity, in the Mucosa of Active Celiac Disease Patients. J. Clin. Gastroenterol. 2016; :. doi: 10.1097/MCG.0000000000000687. PubMed PMID:27636409 .
  4. Pinto-Sánchez, MI, Verdú, EF. Non-coeliac gluten sensitivity: are we closer to separating the wheat from the chaff?. Gut. 2016;65 (12):1921-1922. doi: 10.1136/gutjnl-2016-312471. PubMed PMID:27531827 .
  5. Rey, M, Yang, M, Lee, L, Zhang, Y, Sheff, JG, Sensen, CW et al.. Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease. Sci Rep. 2016;6 :30980. doi: 10.1038/srep30980. PubMed PMID:27481162 PubMed Central PMC4969619.
  6. Pinto-Sánchez, MI, Nachman, FD, Fuxman, C, Iantorno, G, Hwang, HJ, Ditaranto, A et al.. Altered Esophageal Mucosal Structure in Patients with Celiac Disease. Can J Gastroenterol Hepatol. 2016;2016 :1980686. doi: 10.1155/2016/1980686. PubMed PMID:27446827 PubMed Central PMC4904646.
  7. Volta, U, Pinto-Sanchez, MI, Boschetti, E, Caio, G, De Giorgio, R, Verdu, EF et al.. Dietary Triggers in Irritable Bowel Syndrome: Is There a Role for Gluten?. J Neurogastroenterol Motil. 2016;22 (4):547-557. doi: 10.5056/jnm16069. PubMed PMID:27426486 PubMed Central PMC5056565.
  8. Caminero, A, Galipeau, HJ, McCarville, JL, Johnston, CW, Bernier, SP, Russell, AK et al.. Duodenal Bacteria From Patients With Celiac Disease and Healthy Subjects Distinctly Affect Gluten Breakdown and Immunogenicity. Gastroenterology. 2016;151 (4):670-83. doi: 10.1053/j.gastro.2016.06.041. PubMed PMID:27373514 .
  9. McCarville, JL, Caminero, A, Verdu, EF. Novel perspectives on therapeutic modulation of the gut microbiota. Therap Adv Gastroenterol. 2016;9 (4):580-93. doi: 10.1177/1756283X16637819. PubMed PMID:27366225 PubMed Central PMC4913331.
  10. Galipeau, HJ, Verdu, EF. The complex task of measuring intestinal permeability in basic and clinical science. Neurogastroenterol. Motil. 2016;28 (7):957-65. doi: 10.1111/nmo.12871. PubMed PMID:27339216 .
Search PubMed
Share on FacebookTweet about this on TwitterShare on Google+Share on LinkedIn